|
Anthem Biosciences Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
46330.02 Cr.
|
P/BV
|
19.22
|
Book Value (Rs.)
|
42.92
|
|
52 Week High/Low (Rs.)
|
836/702
|
FV/ML
|
2/1
|
P/E(X)
|
102.67
|
|
Bookclosure
|
|
EPS (Rs.)
|
8.04
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR |
| FaceValue | 2.00 | 2.00 | 2.00 |
| | | | |
| PER SHARE RATIOS | | | |
| | | | |
| Basic EPS (Rs.) | 8.07 | 6.48 | 6.75 |
| Diluted EPS (Rs.) | 8.04 | 6.48 | 6.75 |
| Cash EPS (Rs.) | 9.67 | 8.03 | 7.87 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 43.10 | 34.43 | 30.51 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 43.10 | 34.43 | 30.51 |
| Revenue From Operations / Share (Rs.) | 32.99 | 25.39 | 18.53 |
| PBDIT / Share (Rs.) | 13.53 | 10.17 | 8.87 |
| PBIT / Share (Rs.) | 11.93 | 8.71 | 7.75 |
| PBT / Share (Rs.) | 11.75 | 8.54 | 8.72 |
| Net Profit / Share (Rs.) | 8.07 | 6.57 | 6.75 |
| NP After MI And SOA / Share (Rs.) | 8.07 | 6.57 | 6.75 |
| | | | |
| PROFITABILITY RATIOS | | | |
| | | | |
| PBDIT Margin (%) | 41.01 | 40.06 | 47.87 |
| PBIT Margin (%) | 36.17 | 34.30 | 41.84 |
| PBT Margin (%) | 35.61 | 33.62 | 47.05 |
| Net Profit Margin (%) | 24.46 | 25.87 | 36.44 |
| NP After MI And SOA Margin (%) | 24.46 | 25.87 | 36.44 |
| Return on Networth / Equity (%) | 18.72 | 19.08 | 22.12 |
| Return on Capital Employeed (%) | 26.88 | 23.63 | 23.89 |
| Return On Assets (%) | 16.07 | 15.31 | 19.12 |
| Long Term Debt / Equity (X) | 0.01 | 0.05 | 0.05 |
| Total Debt / Equity (X) | 0.04 | 0.12 | 0.07 |
| Asset Turnover Ratio (%) | 0.70 | 0.64 | 0.00 |
| | | | |
| LIQUIDITY RATIOS | | | |
| | | | |
| Current Ratio (X) | 5.32 | 4.38 | 8.07 |
| Quick Ratio (X) | 4.28 | 3.75 | 7.28 |
| Inventory Turnover Ratio (X) | 6.69 | 8.33 | 0.00 |
| | | | |
| COVERAGE RATIOS | | | |
| | | | |
| Interest Coverage Ratio (%) | 73.25 | 59.64 | 74.81 |
| Interest Coverage Ratio (Post Tax) (%) | 44.69 | 39.52 | 48.82 |
